Search

Pharma moving to more restricted drug distribution, in attempt to guard drug supply chain
Ideally, drug supply should be a simple and transparent chain that connects the manufacturer and patient in as few steps as possible. However, in practice it can be a highly circuitous one that includes several intermediaries before reaching a pharmacy. Notwithstanding the possibility that drug integrity can be compromised in transit, complex supply chains risk counterfeit drug entry. 15 May 2008 06:10

Leading ED treatment celebrates five years in South Africa
Lilly's treatment for erectile dysfunction still market leader 24 Apr 2008 08:42

‘Conservative' pharma slow to take advantage of online marketing opportunities
[Dr Sandra Reynolds] While the internet has altered the landscape in the retail sector and revolutionised the airline industry, pharmaceutical companies have been slow to take advantage of the marketing opportunities offered by the internet. However, the same cannot be said of customers, who are increasingly using the web to source information. 23 Apr 2008 08:35

Cash-strapped governments, patent expiries, fuel generics growth
[Pam Narang] Driven by the increasing use of cost-containment measures imposed by cash-strapped governments and fed by a constant stream of patent expiries going forward, the global generics market continues to grow. 17 Apr 2008 06:00

Pharma must adapt to changing market dynamics in 2008
Headaches abound for pharma companies in today's market. Pharma faces growing competition from generics and ‘me-too' drugs, increasingly tough pricing and reimbursement (P&R), a clamp down on healthcare spending, and the need to treat patients for longer due to the aging population. Combined, these factors threaten both current and future revenues, prompting Pharma to adopt a range of corporate strategies to respond to the changing market dynamics, according to a new report by independent market analyst Datamonitor. 11 Apr 2008 06:00

Pfizer Oncology draws top advocates for R&D summit
Leaders of premier advocacy organizations from around the world will meet with Pfizer Oncology to discuss the latest advances in cancer research and identify opportunities to work together. 3 Apr 2008 17:29

Company news: ONTARGET medical programme expected to offer new hope in fighting world's No. 1 killer
The results of the ONTARGET trial, which are expected to provide evidence for the best proven treatment that will save and extend lives as well as enhance the quality of life for people suffering from, or at risk of, heart attacks, strokes and a common form of diabetes are eagerly anticipated. 7 Mar 2008 10:51

Company news: Aspen records 15% year-on-year revenue increase
JSE listed Aspen (Apn), Africa's largest pharmaceutical manufacturer, has recorded consistently positive results for the period ended December 2007. 26 Feb 2008 10:50

Technology to defeat bacterial infections shows positive results
A UK company is leading the use of natural controls against serious bacterial infection and superbugs. Scientists at Biocontrol Ltd have presented at the Bacteriophage 2008 meeting in Hertfordshire a first look at the results of their initial Phase II clinical trial. 26 Feb 2008 08:01

Company news: Health communication lacking among South African couples
More results from the first ever healthy relationships survey have been released with respondents reporting that healthy communication is sorely lacking in the majority of relationships. 14 Feb 2008 15:09

Health experts discuss counterfeit medicine
An international conference discussing threats of counterfeit medicine and their effects on patients in Africa is underway in Johannesburg. 14 Feb 2008 06:26

Adapt or die
Pharmaceutical companies are going to have to adapt or die as patent expiries drag infectious disease market down. 14 Feb 2008 06:22

Company news: ENDORSE trial shows most patients at risk for VTE
The Lancet published ENDORSE, the largest multinational study showing that the majority of hospitalised patients surveyed are at risk for VTE and many do not receive recommended VTE prophylaxis 5 Feb 2008 09:08

Nothing depressing about launch of Cipla's Lexamil 8 May 2008 09:26

Avastin now used for the treatment of patients with metastatic colon cancer in Europe 29 Jan 2008 10:14